Levi & korsinsky reminds novo nordisk a/s investors of the ongoing investigation into potential violations of securities laws - nvo

New york, ny / access newswire / january 24, 2025 / levi & korsinsky notifies investors that it has commenced an investigation of novo nordisk a/s ("novo nordisk a/s") (nyse:nvo) concerning possible violations of federal securities laws. on december 20, 2024, novo issued a press release announcing the below-expected results of their "redefine 1" trial, "a 68-week efficacy and safety trial investigating subcutaneous cagrisema.
NVO Ratings Summary
NVO Quant Ranking